Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
2 Healthcare Stocks That Could Soar Over the Next 5 Years [Yahoo! Finance]
Abivax (ABVX) had its price target raised by Barclays PLC from $142.00 to $148.00. They now have an "overweight" rating on the stock.
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Abivax (ABVX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $160.00 price target on the stock.